This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Erie Indemnity Q3 Earnings Top on Higher Management Fee Revenues
by Zacks Equity Research
ERIE's Q3 results reflect higher management fees and increased net investment income, offset by higher expenses.
Erie Indemnity (ERIE) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Erie Indemnity (ERIE) delivered earnings and revenue surprises of 2.34% and 1.50%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Erie Indemnity Set to Report Q3 Earnings: What to Expect
by Zacks Equity Research
ERIE's third-quarter results are likely to benefit from improved performance at both the personal and commercial lines.
Brown & Brown (BRO) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Brown & Brown (BRO) delivered earnings and revenue surprises of 4.60% and 2.20%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Aon (AON) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Aon (AON) delivered earnings and revenue surprises of 11.02% and 0.53%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Is ProShares S&P MidCap 400 Dividend Aristocrats ETF (REGL) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for REGL
Buy 4 Low-Beta Stocks & Forget About Volatility: ERIE, SFM, AVO, ABL
by Nilanjan Banerjee
It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. ERIE, SFM, AVO & ABL are well-poised to gain.
Erie Indemnity and Dollar Tree have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Erie Indemnity and Dollar Tree have been highlighted as Zacks Bull and Bear of the Day
Bull of the Day: Erie Indemnity (ERIE)
by Derek Lewis
Since becoming a Zacks Rank #1 (Strong Buy) on July 30th, ERIE shares have gained nearly 20%, widely outperforming relative to the S&P 500.
Erie Indemnity (ERIE) Is Up 2.90% in One Week: What You Should Know
by Zacks Equity Research
Does Erie Indemnity (ERIE) have what it takes to be a top stock pick for momentum investors? Let's find out.
Is SPDR S&P Insurance ETF (KIE) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for KIE
Zacks Investment Ideas feature highlights: Erie Indemnity, Duolingo and Maplebear
by Zacks Equity Research
Erie Indemnity, Duolingo and Maplebear have been highlighted in this Investment Ideas article.
3 Powerful Examples of the Zacks Rank: ERIE, DUOL, CART
by Derek Lewis
Listening to the Zacks Rank can consistently result in market-beating gains, as positive earnings estimate revisions provide shares the fuel needed to move higher in the near term.
Buy These 5 Nasdaq Stocks With Double-Digit Returns in the Past Month
by Nalak Das
Five recently thriving Nasdaq Composite-listed stocks are: AFRM, ACGL, COO, ERIE, WDAY.
Zacks.com featured highlights include Erie Indemnity, Sprouts Farmers Market, Newmont and Unilever
by Zacks Equity Research
Erie Indemnity, Sprouts Farmers Market, Newmont and Unilever are part of the Zacks Screen of the Week article.
Volatility Concerns? Bet on 4 Low-Beta Stocks: ERIE, SFM, NEM, UL
by Nilanjan Banerjee
It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. ERIE, SFM, NEM and UL are well-poised to gain.
Should First Trust Value Line Dividend ETF (FVD) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FVD
Aon Boosts HR Insights With Enhanced Radford McLagan Database
by Zacks Equity Research
AON enhances solutions for human capital clients with the launch of Radford McLagan Compensation Database.
Bet on These 4 Low-Beta Stocks to Combat Market Volatility
by Nilanjan Banerjee
It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. Erie Indemnity (ERIE), Sprouts Farmers (SFM), Newmont (NEM) & Calavo (CVGW) are well-poised to gain.
3 Reasons Why Growth Investors Shouldn't Overlook Erie Indemnity (ERIE)
by Zacks Equity Research
Erie Indemnity (ERIE) could produce exceptional returns because of its solid growth attributes.
3 Buy Rated Finance Stocks Flashing Relative Strength: HRTG, ERIE, EZPW
by Derek Lewis
Recently, several top-ranked finance stocks have shown strength, outperforming nicely. But what's driving the moves?
Arthur J. Gallagher (AJG) Gains 25% YTD: More Upside Left?
by Zacks Equity Research
Arthur J. Gallagher (AJG) is poised to grow from the solid performance of its Brokerage and Risk Management segments, strategic buyouts and effective capital deployment.
Navigate Market Turbulence With These 4 Low-Beta Stocks
by Nilanjan Banerjee
It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. Erie Indemnity (ERIE), TreeHouse (THS), HII (HII) and ADMA Biologics (ADMA) are well-poised to gain.
Is Erie Indemnity (ERIE) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
Erie Indemnity (ERIE) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Earnings Estimates Moving Higher for Erie Indemnity (ERIE): Time to Buy?
by Zacks Equity Research
Erie Indemnity (ERIE) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.